ANL · Adlai Nortye Group Ltd ADR
United States · RS rating 46 · As of 2026-10-14
| Price | 10.88 USD |
|---|---|
| 1-day change | -7.4% |
| RS rating (overall / 1M / 3M / 12M) | 46 / 7 / 46 / 99 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 25 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +34.5% |
| Market cap (USD) | $791.4M |